Logo image
The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL
Journal article   Peer reviewed

The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL

Erik L Brincks, Prajwal Gurung, Ryan A Langlois, Emily A Hemann, Kevin L Legge and Thomas S Griffith
The Journal of immunology (1950), Vol.187(9), pp.4581-4588
11/01/2011
DOI: 10.4049/jimmunol.1002241
PMCID: PMC3197947
PMID: 21940678

View Online

Abstract

An immune response of appropriate magnitude should be robust enough to control pathogen spread but not simultaneously lead to immunopathology. Primary infection with influenza A virus (IAV) results in a localized pulmonary infection and inflammation and elicits an IAV-specific CD8 T cell immune response necessary for viral clearance. Clearance of IAV-infected cells, and recovery from infection, is mediated by perforin/granzyme B- and Fas/FasL-mediated mechanisms. We recently reported that TRAIL is another means by which IAV-specific CD8 T cells can kill IAV-infected cells. The current study examined the role of TRAIL in the pulmonary CD8 T cell response to a clinically significant IAV [A/PR/8/34 (PR8; H1N1)] infection (i.e., leads to observable, but limited, morbidity and mortality in wild-type [WT] mice). Compared with WT mice, IAV-infected Trail(-/-) mice experienced increased morbidity and mortality despite similar rates of viral clearance from the lungs. The increased morbidity and mortality in Trail(-/-) mice correlated with increased pulmonary pathology and inflammatory chemokine production. Analysis of lung-infiltrating lymphocytes revealed increased numbers of IAV-specific CD8 T cells in infected Trail(-/-) mice, which correlated with increased pulmonary cytotoxic activity and increased pulmonary expression of MIG and MIP-1α. In addition, there was decreased apoptosis and increased proliferation of IAV-specific CD8 T cells in the lungs of Trail(-/-) mice compared with WT mice. Together, these data suggest that TRAIL regulates the magnitude of the IAV-specific CD8 T cell response during a clinically significant IAV infection to decrease the chance for infection-induced immunopathology.
Influenza A Virus, H1N1 Subtype - immunology Lung - pathology CD8-Positive T-Lymphocytes - pathology Dose-Response Relationship, Immunologic Mice, Inbred C57BL Influenza A Virus, H3N2 Subtype - immunology Mice, Knockout Lung - virology Animals Orthomyxoviridae Infections - mortality TNF-Related Apoptosis-Inducing Ligand - physiology CD8-Positive T-Lymphocytes - virology Survival Analysis TNF-Related Apoptosis-Inducing Ligand - deficiency Mice Mice, Inbred BALB C Epitopes, T-Lymphocyte - immunology CD8-Positive T-Lymphocytes - immunology Orthomyxoviridae Infections - virology TNF-Related Apoptosis-Inducing Ligand - genetics Lung - immunology Orthomyxoviridae Infections - immunology

Details

Metrics

Logo image